Westport, CT, June 20, 2023 - Balance Point Capital Advisors, LLC ("Balance Point"), in conjunction with its affiliated fund, Balance Point Capital Partners V, L.P., is pleased to announce its investment in Innovia Medical (“Innovia”, “the Company”).  Balance Point provided debt and equity capital to facilitate Inverness Graham Investments’ (“IGI”) acquisition of the Company.

 

 

“Balance Point is excited to partner with Innovia and the IGI team as the Company continues to execute its playbook through organic and acquisitive growth.” said Balance Point Partner Adam Sauerteig.  “Innovia’s portfolio of products has a clear value proposition within the markets it serves, and Balance Point looks forward to supporting the Company as it continues to deliver unique offerings across medical specialties.”  

 

Terry Meredith, CEO of Innovia, said “Balance Point took the time to meet the management team and understand our business. Combined with its capital creativity, they will be essential as we continue to pursue our growth objectives.  We are very pleased to be partnering with Balance Point on this transaction.”

 

“We are thrilled to work with Balance Point again, and look forward to a productive partnership in support of Innovia” added IGI Vice President Trey Simpson.

 

Balance Point is an alternative investment manager focused on the lower middle market. With approximately $1.7 billion in assets under management, Balance Point invests debt and equity capital in select lower middle market companies across a variety of investment vehicles. Balance Point takes a long-term, partnership approach to investing and is committed to building lasting relationships with its partners, management teams and intermediaries.

Balance Point is a registered investment advisor. Further information is available at www.balancepointcapital.com.

 

Innovia is a family of specialty surgical companies that are passionately committed to partnering with medical professionals to help elevate the delivery of patient care and improve clinical outcomes. Innovia has built a diverse portfolio of 550 products backed by strong intellectual property and supplies medical products to facilities in over 70 countries.

For more information visit www.innoviamedical.com